Access to Askel Healthcare’s investor event recording

Askel Healthcare has appointed globally renowned orthopedic surgeons and sports medicine specialists to its new Clinical Advisory Board to drive change in the treatment of knee cartilage repair

Invitation to Askel Healthcare investor event on 24 May at 16:00 EEST

Askel Healthcare to raise 5 million euros for clinical research of its COPLA® -implant to treat knee pain caused by cartilage damage

Askel Healthcare’s COPLA® implant on EVT, the national public television network of Estonia

First knee cartilage implant tested on Estonian can save people from knee pain

Askel Healthcare has reached an important milestone towards marketing authorization of the COPLA® implant in EU and the USA

First research patient operated in Estonia with Askel Healthcare’s COPLA® knee cartilage repair implant